Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multispectral Imaging for Gastric Neoplasia Detection
NCT02207959Phase 1Terminated
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 1, single-blind trial of proflavine hemisulphate in gastric cancer (GC) and gastric dysplasia. Primary endpoint: Presence of gastric neoplasia at Day 1. Started Jan 2015; status: terminated.
02
Drugs
proflavine hemisulphate
03
Conditions
gastric cancer (GC)gastric dysplasia
Beyond the preview
Go deeper on NCT02207959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02207959.